Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:alternativeName |
ERUCOV-VAC
|
| gptkbp:clinicalTrialPhase |
Phase III
|
| gptkbp:countryOfOrigin |
gptkb:Turkey
|
| gptkbp:developedBy |
gptkb:Turkey
gptkb:Erciyes_University Health Institutes of Turkey |
| gptkbp:emergencyServices |
gptkb:Turkey
|
| gptkbp:form |
2 doses
|
| gptkbp:founder |
Aykut Özdarendeli
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:storage |
2-8°C
|
| gptkbp:target |
gptkb:COVID-19
|
| gptkbp:type |
gptkb:vaccine
|
| gptkbp:yearOfAuthorization |
2021
|
| gptkbp:bfsParent |
gptkb:COVID-19_pandemic_response_in_Turkey
gptkb:COVID-19_pandemic_(real_event) |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
Turkovac
|